We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

148 hedge funds and large institutions have $513M invested in Cytokinetics in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

931% more call options, than puts

Call options by funds: $3.93M | Put options by funds: $381K

233% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 6

46% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 37

10% more funds holding

Funds holding: 134 → 148 (+14)

2% more capital invested

Capital invested by funds: $502M → $513M (+$11.3M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.48% less ownership

Funds ownership: 77.37% → 76.89% (-0.48%)

Holders
148
Holders Change
+14
Holders Change %
+10.45%
% of All Funds
3.25%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
54
Reduced
37
Closed
6
Calls
$3.93M
Puts
$381K
Net Calls
+$3.55M
Net Calls Change
-$2.6M

Top Buyers

1
Federated Hermes
Federated Hermes
Pennsylvania
+$11.4M
2
DCM
Driehaus Capital Management
Illinois
+$6.68M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$4.39M
4
N
Nuveen
North Carolina
+$2.82M
5
SI
Sofinnova Investments
California
+$2.65M

Top Sellers

1
BI
BVF Inc
California
-$12.7M
2
WA
Wasatch Advisors
Utah
-$9.48M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.74M
4
OM
Opaleye Management
Massachusetts
-$3.14M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
101
Algert Global
California
$164K +$181K +14,388 New
TAM
102
Tyers Asset Management
Texas
$146K – – –
HighTower Advisors
103
HighTower Advisors
Illinois
$145K – – –
MFG
104
Magnus Financial Group
New York
$135K – – –
RCM
105
Riverhead Capital Management
Delaware
$131K – – –
BFM
106
Boothbay Fund Management
New York
$130K +$143K +11,411 New
TRSOTSOK
107
Teachers Retirement System of the State of Kentucky
Kentucky
$122K – – –
PI
108
PineBridge Investments
New York
$119K +$50K +3,984 +62%
AB
109
Amalgamated Bank
New York
$115K -$1.47K -117 -1%
NA
110
Neuburgh Advisers
California
$115K – – –
BC
111
Birchview Capital
Vermont
$114K – – –
Victory Capital Management
112
Victory Capital Management
Texas
$95K +$104K +8,314 New
Bank of Montreal
113
Bank of Montreal
Ontario, Canada
$94K +$3.2K +255 +3%
BNP Paribas Financial Markets
114
BNP Paribas Financial Markets
France
$88.3K +$33.3K +2,650 +52%
MCIM
115
Meadow Creek Investment Management
Georgia
$84K – – –
Simplex Trading
116
Simplex Trading
Illinois
$77K +$85.3K +6,795 New
AIP
117
Ameritas Investment Partners
Nebraska
$53K – – –
Zurich Cantonal Bank
118
Zurich Cantonal Bank
Switzerland
$48K +$23.4K +1,865 +79%
PNC Financial Services Group
119
PNC Financial Services Group
Pennsylvania
$40K -$48.5K -3,862 -52%
MAM
120
Meeder Asset Management
Ohio
$31K -$92.2K -7,342 -73%
LTFS
121
Ladenburg Thalmann Financial Services
Florida
$31K – – –
SWA
122
Sutton Wealth Advisors
Florida
$25.2K – – –
MOACM
123
Mutual of America Capital Management
New York
$25K +$1.29K +103 +5%
LIA
124
LS Investment Advisors
Michigan
$21K – – –
Royal Bank of Canada
125
Royal Bank of Canada
Ontario, Canada
$12K -$12.8K -1,023 -49%
3 4
5
6 7

CYTK Hedge Fund Activity: Q3 2019 in Review

148 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2019, worth a combined $513M — up 2.2% from $502M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CYTK positions and 6 closed out — a net gain of 14 holders — while 54 added to existing stakes and 37 trimmed.

The largest buyer was Federated Hermes, adding an estimated $11.4M. The largest seller was BVF Inc, cutting an estimated $12.7M.

  • 148 institutional investors held Cytokinetics (CYTK) as of Q3 2019, up from 134 in Q2 2019.
  • Funds reported $513M of Cytokinetics stock for Q3 2019, up 2.2% quarter-over-quarter.
  • 20 funds opened new Cytokinetics positions in Q3 2019 and 6 closed out, a net change of +14 holders.
  • The largest Cytokinetics buyer in Q3 2019 was Federated Hermes, an estimated $11.4M added.
  • The largest Cytokinetics seller in Q3 2019 was BVF Inc, an estimated $12.7M sold.

Based on aggregated 13F filings for Q3 2019.